ISPOR - PSY4 Budget Impact of Baricitinib for Moderate-to-Severe Atopic Dermatitis Patients with an Inadequate Response to Topical Treatments

Full Text

PSY4 Budget Impact of Baricitinib for Moderate-to-Severe Atopic Dermatitis Patients with an Inadequate Response to Topical Treatments

Abstract

Authors

C. Fenske K. Rosettie C. Ferrufino M. Borns B. Atiya N. Johnson E. Wehler

Back to Volume 24, Supplemental S1

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now